Retinopathy in an obesity WHO III cohort: prevalence and risk factors.
To assess retinopathy and its risk factors in an obesity WHO III cohort.



In theMannheim Obesity Study, 277 subjects with obesity WHO III aged 18-64 years were examined in a cross-sectional approach. Screening for retinopathy was performed using 3-field retinal photography. Endothelial function was assessed using arteriole-to-venule ratio and flicker light analysis. Subjects with and without retinopathy were analysed for anthropometry, metabolic, vascular and renal parameters.



Retinopathy was found in 18 of the 277 subjects (6.5%). Prevalence of retinopathy was 16.7% in subjects with and 3.4% in subjects without diabetes mellitus. Between subjects with and without retinopathy there were significant differences in diabetes prevalence (61.1% vs 21.7%, p<0.001), systolic blood pressure (145.56 vs 131.73 mm Hg, p=0.005), intima-media thickness (0.7 vs 0.59 mm, p=0.034), dilatation of retinal veins in response to flicker light (2.24% vs 4.28%, p=0.004) and creatinine (0.92 vs 0.83 mg/dL, p=0.011). Stepwise logistic regression analysis revealed that the presence of diabetes mellitus led to an 8.3-fold increased risk for retinopathy (OR 8.3, p=0.049, 95% CI 1.01 to 67.49), whereas risk for retinopathy decreased by nearly 50% (OR 0.54, p=0.032, 95% CI 0.30 to 0.95) with each percentage increase in venous dilatation in response to flicker light.



Retinopathy prevalence in our obesity WHO III cohort is low. Presence of diabetes mellitus is the most important risk factor for retinopathy. Preserved venular function indicates protection from retinopathy.



NCT00770276, Results.
5th Medical Department, Universitätsmedizin Mannheim, University of Heidelberg, Mannheim, Germany.
Juri
J
Mattern
5th Medical Department, Universitätsmedizin Mannheim, University of Heidelberg, Mannheim, Germany.
Alexander
A
Lammert
Surgical Department, Universitätsmedizin Mannheim, University of Heidelberg, Mannheim, Germany.
Mirko
M
Otto
5th Medical Department, Universitätsmedizin Mannheim, University of Heidelberg, Mannheim, Germany.
Hans-Peter
HP
Hammes
D000293:Adolescent; D000328:Adult; D015992:Body Mass Index; D003430:Cross-Sectional Studies; D005260:Female; D005858:Germany / Q000453:epidemiology; D006801:Humans; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000097:blood / Q000150:complications* / Q000453:epidemiology; D015995:Prevalence; D012164:Retinal Diseases / Q000175:diagnosis / Q000453:epidemiology* / Q000209:etiology; D012171:Retinal Vessels / Q000000981:diagnostic imaging* / Q000503:physiopathology; D018570:Risk Assessment; D012307:Risk Factors; D014664:Vasodilation / Q000502:physiology; D055815:Young Adult
D008055:Lipids
Retina